Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
Missouri hospital launches innovative pilot program providing medication and guaranteed virtual addiction appointments within 72 hours to rural patients with opioid use disorder.
University of Kentucky researchers find that experimental Alzheimer's medication MW150 could reduce brain inflammation and neural damage during alcohol withdrawal, potentially lowering relapse rates.
Maryland's new public dashboard tracks $747 million in opioid settlement funds, setting a new standard for accountability in how states distribute restitution dollars from pharmaceutical companies.
Three dead and 25 exposed including 18 first responders in Mountainair, New Mexico, revealing the escalating risks of potent fentanyl analogs
Single dose of psilocybin with therapy support produced rapid, sustained reductions in suicidal thoughts among treatment-resistant patients
The Department of Veterans Affairs begins groundbreaking clinical trial testing MDMA-assisted therapy for veterans struggling with PTSD and alcohol use disorder, marking a significant federal investment in psychedelic medicine.
The Virginia Harm Reduction Coalition deploys distinctive purple dispensing boxes across Southwest Virginia, making life-saving naloxone freely available in communities with some of the state's highest overdose rates.
Preliminary CDC data shows approximately 70,000 Americans died of drug overdoses in 2025, the lowest since before the pandemic, though experts caution the crisis is far from over.
New research reveals how cAMP signaling in brain neurons drives GLP-1 weight loss effects, opening pathways to enhance addiction treatments.